Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience

Involved-field radiotherapy (IFRT) has been used in the peritransplantation period to minimize the risk of disease recurrence after autologous hematopoietic stem-cell transplantation in patients with bulky or residual lymphoma after salvage chemotherapy. However, the optimal timing of radiotherapy still remains under investigation. We provided IFRT early after transplantation in high-risk patients and demonstrated high survival rates with extremely low toxicity.